Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
September 18, 2025
Rare Diseases Weekly News – September 18th 2025
September 18, 2025
Cell and Gene Therapy Weekly News – September 18th 2025
September 17, 2025
Neuroscience Weekly News – September 17th 2025
September 17, 2025
Immunology Weekly News – September 17th 2025
September 17, 2025
EADV 2025 Preview: Dermatology and Venereology Highlights to Watch
September 17, 2025
Women’s Health Weekly News – September 17th 2025
September 16, 2025
Obesity Weekly News – September 16th 2025
September 16, 2025
Endocrinology Weekly Update – September 16th 2025
September 16, 2025
EASD 2025 Preview: Key Diabetes Highlihts to Watch
September 15, 2025
Artificial Intelligence and Digital Health Weekly News – September 15th 2025
September 15, 2025